December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Intravitreal Triamcinolone Does Not Change Vascular Endothelial Growth Factor (VEGF) mRNA Expression in Rat Retina
Author Affiliations & Notes
  • H Gao
    Dept of Ophthalmology Baylor College of Medicine Houston TX
  • X Qiao
    Dept of Cell Biology & Anatomy Louisiana State University School of Medicine Shreveport LA
  • WF Mieler
    Dept of Ophthalmology Baylor College of Medicine Houston TX
  • AR McPherson
    Dept of Ophthalmology Baylor College of Medicine Houston TX
  • ER Holz
    Dept of Ophthalmology Baylor College of Medicine Houston TX
  • Footnotes
    Commercial Relationships   H. Gao, None; X. Qiao, None; W.F. Mieler, None; A.R. McPherson, None; E.R. Holz, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3918. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Gao, X Qiao, WF Mieler, AR McPherson, ER Holz; Intravitreal Triamcinolone Does Not Change Vascular Endothelial Growth Factor (VEGF) mRNA Expression in Rat Retina . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3918.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: It has been reported that intravitreal triamcinolone inhibits choroidal neovasculization (CNV) in exudative age-related macular degeneration (AMD) and in laser-induced CNV animal model. The mechanism of inhibition of angiogenesis by triamcinolone remains unknown. Since vascular endothelial growth factor (VEGF) is a major stimulator of CNV, we examined whether triamcinolone can regulate VEGF expression in rat retina. Methods: Triamcinolone acetonide of 320 µg in 8 µl was injected intravitreally into eyes of normal adult Sprague-Dawley rats, and saline of equal volume was injected into fellow eyes of each animal as controls. Animals were sacrificed at 3 days, 1 week, and 2 weeks after injection (N = 3 for each stage), and eyes were processed for in situ hybridization using radio-labeled rat VEGF riboprobes. Results: VEGF mRNA expression signals are localized in choroid, retinal pigment epithelium (RPE), cells in the inner nuclear layer, and ganglion cells, as reported in previous studies. High levels of hybridization signals are present in choroid and cells in the INL. Image analyses show no significant difference in VEGF expression levels in these cells between triamcinolone- and saline-injected eyes from 3 days to 2 weeks following injection. Conclusion: Our studies show that intravitreal triamcinolone does not change VEGF mRNA expression 2 weeks after injection in normal adult rats. It remains to be determined whether triamcinolone regulates VEGF expression in CNV caused by exudative AMD or induced by laser treatment in animal models.

Keywords: 308 age-related macular degeneration • 346 choroid: neovascularization • 423 growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×